A randomised controlled trial evaluating the effects of long-term low-dose corticosteroid therapy compared to placebo on flare rates during maintenance therapy for proliferative lupus nephritis: a pilot study
Not Applicable
Completed
- Conditions
- Systemic lupus erythematosus and lupus nephritisMusculoskeletal DiseasesSystemic lupus erythematosus
- Registration Number
- ISRCTN31327267
- Lead Sponsor
- niversity of Calgary (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1. 18 years of age or older
2. American College of Rheumatology defined systemic lupus erythematosus
3. International Society of Nephrology/Renal Pathology Society (ISN/RPS) class III or IV lupus nephritis on last renal biopsy
4. In complete or partial remission
5. Currently on corticosteroids
6. Informed consent
Exclusion Criteria
1. Receiving steroids for a non-Systemic Lupus Erythematosus (SLE) indication
2. Currently pregnant
3. On a form of renal replacement therapy or having received a renal transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method